| View |
|
DRP-5493-04
|
Etoricoxib
|
Unbranded
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Coxib)
|
XL Laboratories Pvt. Ltd.
|
India
|
Renewal
|
21 March 2024
|
28 August 2029
|
| View |
|
DRP-5529-03
|
Tamsulosin Hydrochloride
|
Tamzor
|
200 mcg
|
Enteric-Coated Tablet
|
Alpha-Adrenoreceptor Antagonist
|
Unicure Remedies Pvt. Ltd.
|
India
|
Renewal
|
19 April 2024
|
23 September 2029
|
| View |
|
DRP-5540-02
|
Iron Sucrose
|
Maxifer
|
20 mg/mL (100mg/5mL)
|
Solution for Injection (IV)
|
Anti-anemic
|
Gland Pharma Limited
|
India
|
CLIDP Conversion
|
09 December 2023
|
08 July 2025
|
| View |
|
DRP-5894-04
|
Ondansetron (as Hydrochloride)
|
Danaset
|
2 mg / mL
|
Solution for Injection (I.M/I.V)
|
Antiemetic
|
Cadila Pharmaceuticals Ltd
|
India
|
Renewal
|
27 March 2024
|
11 December 2029
|
| View |
|
DRP-5897-01
|
Bisacodyl
|
None
|
5 mg
|
Enteric-Coated Tablet
|
Laxative
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
08 December 2023
|
30 January 2027
|
| View |
|
DRP-5909-08
|
Pantoprazole (as sodium sesquihydrate)
|
Prazlax
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 December 2023
|
12 January 2025
|
| View |
|
DRP-5926-08
|
Cefixime (as Trihydrate)
|
Xyphix
|
100 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
26 November 2023
|
12 October 2026
|
| View |
|
DRP-5926-09
|
Cefixime (as Trihydrate)
|
Cefixsave
|
100 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
14 December 2023
|
12 October 2026
|
| View |
|
DRP-5932-03
|
Clarithromycin
|
Clarisave
|
125 mg / 5 mL
|
Granules for Oral Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
14 December 2023
|
21 February 2027
|
| View |
|
DRP-5985-05
|
Domperidone
|
DompeSave
|
1 mg / mL
|
Suspension
|
Propulsives
|
Opal Laboratories (PVT.) Limited
|
Pakistan
|
CLIDP Conversion
|
14 December 2023
|
11 November 2026
|
| View |
|
DRP-6260-03
|
Cetirizine Hydrochloride
|
None
|
10 mg
|
Tablet
|
Antihistamine (Piperazine Derivative)
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
13 December 2023
|
03 June 2028
|
| View |
|
DRP-6561-01
|
Pantoprazole (as sodium)
|
None
|
40 mg
|
Powder for Solution for Injection (IV)
|
Proton Pump Inhibitor
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 December 2023
|
04 March 2026
|
| View |
|
DRP-6609-06
|
Ondansetron (as hydrochloride dihydrate)
|
Zukastop
|
8 mg
|
Film-Coated Tablet
|
Antiemetic (5-HT3-Receptor Antagonist)
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 December 2023
|
30 March 2026
|
| View |
|
DRP-6619-02
|
Alendronic acid (as Alendronate Sodium Trihydrate) + Cholecalciferol (Vitamin D3)
|
Bonicent
|
70 mg/5,600 I.U.
|
Tablet
|
Bisphosphonate/Vitamin Combination
|
Daewon Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
13 December 2023
|
06 April 2026
|
| View |
|
DRP-6703-03
|
Cefuroxime (as sodium)
|
Xefu
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporins)
|
Phil Inter Pharma Co., Ltd
|
Vietnam
|
CLIDP Conversion
|
09 December 2023
|
24 May 2026
|
| View |
|
DRP-6966-04
|
Phenylephrine Hydrochloride + Brompheniramine Maleate
|
Neo-Fron
|
1 mg/0.80 mg per mL
|
Syrup (Oral Drops)
|
Nasal Decongestant/Antihistamine
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
22 November 2023
|
13 December 2026
|
| View |
|
DRP-7037-04
|
Rosuvastatin (as Calcium)
|
None
|
10 mg
|
Film Coated Tablet
|
HMG CoA reductase inhibitor
|
Rhydburg Pharmaceuticals Ltd
|
India
|
CLIDP Conversion
|
13 December 2023
|
10 February 2026
|
| View |
|
DRP-7049-02
|
Etoricoxib
|
Ecoxia-90
|
90 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
13 December 2023
|
28 August 2027
|
| View |
|
DRP-7097-06
|
Ursodeoxycholic Acid
|
Urdoxy
|
300 mg
|
Film-Coated Tablet
|
Bile Salt
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
09 December 2023
|
14 March 2027
|
| View |
|
DRP-7387-08
|
Vancomycin (as Hydrochloride)
|
None
|
1 g
|
Powder for Injection (I.V. Infusion)
|
Antibacterial (Glycopeptide)
|
Swiss Parenterals Ltd. (Block-B)
|
India
|
CLIDP Conversion
|
03 December 2023
|
04 October 2027
|